Travis Karg
5Patents
3h-index
3Co-inventors
46Inventor score
Filing activity: Mar 2, 2009 → Jun 29, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7998967B2 | Methotrexate adjuvants to reduce toxicity and methods for using the same | Human Necessities | 7 | Active |
| US8853227B2 | Methotrexate adjuvants to reduce toxicity and methods for using the same | Human Necessities | 6 | Active |
| US9382287B2 | Methotrexate adjuvants to reduce toxicity and methods for using the same | Human Necessities | 3 | Active |
| USRE48253E1 | Methotrexate adjuvants to reduce toxicity and methods for using the same | General | 3 | Active |
| US10660318B2 | Non-mammalian RAS transgenic animal model | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.